DIGNITANA CONTINUES U.S. GROWTH WITH EIGHT NEW LOCATIONS
Lund, Sweden - October 11, 2017 - Dignitana AB, a world leader in medical scalp cooling technology and manufacturer of The DigniCap® Scalp Cooling System, announced today that Florida Cancer Specialists (FCS), the largest independent medical oncology/hematology practice in the United States, will offer DigniCap® to patients at eight more of its medical facilities. Headquartered in Fort Myers, Florida Cancer Specialists has over 200 physicians, and 160 nurse practitioners and physician assistants who deliver cancer care at nearly 100 FCS locations. The DigniCap® Scalp Cooling System is currently available at three FCS locations.
With these new site additions, DigniCap® will be available at 103 cancer clinics in 21 states, helping thousands of patients in the United States each year minimize chemotherapy-induced hair loss.
The following Florida Cancer Specialists sites are now contracted to offer the DigniCap® Scalp Cooling System:
Jacksonville, Florida
Jacksonville Beach, Florida
Fleming Island, Florida
Jacksonville, Florida
Jacksonville, Florida
St. Augustine, Florida
Jacksonville, Florida
Middleburg, Florida
“We are proud to have these additional Florida Cancer Specialists locations join the Dignitana roster of prestigious facilities now offering scalp cooling therapeutics through their cancer care regimens,” said William Cronin, Chief Executive Officer of Dignitana, Inc. “Hair loss from chemotherapy is a significant contributor to the quality of life for cancer patients. We look forward to continuing our work with the experienced clinical team at Florida Cancer Specialists to provide scalp cooling to patients across Florida.”
With October 1stkicking off Breast Cancer Awareness Month, scalp cooling has taken root in America and is now on its way to becoming standard medical procedure. In addition to breast cancer, as the first and only scalp cooling device FDA-cleared for use with solid tumor cancers, medical facilities in the U.S. may now also use DigniCap® to reduce alopecia in patients being treated for prostate, ovarian, uterine and other solid tumor cancers. This expands the potential reach for the device to approximately 800,000 cancer patients annually (cancer.org).
Press Contact – USA Corporate Contact – Sweden
Caren Browning Johan Ericsson, VD
King + Company Dignitana AB
00 1 212 561 7464 +46 46 163092
caren.browning@kingcompr.com johan.ericsson@dignitana.se
About Dignitana AB (publ)
Dignitana is a Swedish public company based in Lund and manufacturer of the medical cooling device DigniCap®. Dignitana AB is listed on Nasdaq First North Stockholm and has appointed Erik Penser Bank as Certified Adviser. Headquartered in Dallas Texas, Dignitana, Inc. is the U.S. subsidiary of Dignitana AB. For more information visit www.dignitana.se
About The DigniCap® Scalp Cooling System
DigniCap® is a patented scalp cooling system that offers cancer patients the ability to keep their hair during chemotherapy. DigniCap® provides continuous cooling with high efficacy, safety and acceptable patient comfort. www.dignicap.com
This information is information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, by the above contact, for publication at 8:00 am (CEST), 11 October, 2017.
Tags: